14/11/2017 18:10:21

Sonor Investments Limited Reports Third Quarter Financial Results

TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Sonor Investments Limited (TSXV:SNI.PR.A) today reported its financial results for the nine months ended September 30, 2017.   

        
  9 months ended September 30  3 months ended September 30
  2017 2016  2017 2016 
  $000 $000  $000 $000 
           
Revenue 4,895 4,863  117 497 
           
Net Income (loss) 4,510 4,483  (22)355 
           
           

Michael Gardiner, Chairman and CEO, stated that as at September 30, 2017 the Company’s assets totaled $65.8 million.  These assets included $10.5 million of marketable securities, $35.6 million in a private investment and $19.7 million of cash, cash equivalents and short term investments. 

During the nine months ended September 30, 2017, the Company realized $1,102,000 of net capital gains on the sale of investments.  In the comparable period for 2016 the Company realized $1,095,000 of net capital gains on the sale of investments. During the three months ended September 30, 2017 there were no capital gains compared to $358,000 of net capital gains on the sale of investments during the three months ended September 30, 2016. 

During the period under review, the Company has maintained net assets and qualified investments in excess of the amounts prescribed under the share conditions pertaining to the First Preference Shares in its capital stock.

Sonor Investments Limited is an investment company located in Toronto, Canada.  The First Preference Shares of Sonor trade on The TSX Venture Exchange under the symbol SNI.PR.A.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Company Contacts:

Mr. Michael Gardiner

Chairman and CEO

(416) 369-1499 

Mr. David Middleton

Treasurer & CFO

(416) 369-1499

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
17 Nov
ALMB
Når man dagligt læser indlæg fra Alpehuen, Mackkeith, Malurt, EMEA (MENA), Powertrade som via en flo..
30
17 Nov
PNDORA
Om nogen, har jeg ikke meget tilovers for GW, men jeg har tilladt mig at anmelde dit indlæg. Nu må i..
29
20 Nov
I:SP500
God aften   Gå lige ind under Conference Board i USA og læs, at de ledende indikatorer steg med hele..
25
16 Nov
NOVO-B
Og Goodwrench, Baronen og marc55
25
20 Nov
VWS
Roland, nu må du simpelthen stoppe. Det her er simpelthen for ynkeligt, hvordan kan du være så selvi..
23
17 Nov
OMXC20
  Her kommer en kort gennemgang og forklaring på, hvorfor aktietilbagekøb både kan være rigtig godt ..
23
21 Nov
PNDORA
Hej Roland.   Dem du prøver at råde om aktiehandel, fortjener at vide hvilken tåbe, der prøver at rå..
20
18 Nov
I:NDX
Der er efterhånden alt for få på EI, der bruger hovedparten af deres tid på at tjene penge på aktier..
18
19 Nov
PNDORA
Hvad skal vi med millionærklubben når vi har roland333 
17
16 Nov
VWS
Lavede en kæmpe fodfejl med Vestas. Købte i den private frie pot 1200 stk med gak 402,8 fordi jeg..
15

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

22/11/2017 10:18:00
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

21/11/2017 15:35:27
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Alliance Trust PLC : Net Asset Value(s)

21/11/2017 13:37:22
ALLIANCE TRUST PLC                                    At the close of business on Monday 20 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.0p -       including income, 787.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inc..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Newtek Technology Solutions Joins the VMware Cloud Provider™ Program
2
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
3
Sprouts Farmers Market to Present at the Barclays 2017 Eat, Sleep, Play – It’s Not All Discretionary Conference
4
Franklin Electric Launches Four New Key Dealer Tutorial Videos To Help Contractors Maximize Program Value
5
Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 November 2017 14:44:46
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB3 - 2017-11-22 15:44:46 - 2017-11-22 14:44:46 - 1000 - Website: OKAY